Clinical Trial Update: Methylnaltrexone vs Erythromycin for Facilitating Gastric Emptying Time in Critically Ill Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing methylnaltrexone and erythromycin to facilitate gastric emptying in patients with gastroparesis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroparesis

Drugs mentioned

• ERYTHROMYCIN (ERYTHROMYCIN)
• RELISTOR (methylnaltrexone)

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: Gastroparesis | Phase 2 | Status: TERMINATED